European Journal of Hospital Pharmacy

Article	Citations
Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 2	35
Antifungal drug resistance: an update	34
Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19	34
CLEO: a multidimensional tool to assess clinical, economic and organisational impacts of pharmacists’ interventions	32
Severe and fatal medication errors in hospitals: findings from the Norwegian Incident Reporting System	27
Automation of in-hospital pharmacy dispensing: a systematic review	27
Results of EAHP’s 2019 Medicines Shortages Survey	23
Effectiveness, safety and cost analysis of dalbavancin in clinical practice	21
Implementation of a novel home delivery service during pandemic	21
Cost-effectiveness analysis of pembrolizumab plus standard chemotherapy versus chemotherapy alone for first-line treatment of metastatic non-squamous non–small-cell lung cancer in China	18
Observational study on off-label use of tocilizumab in patients with severe COVID-19	17
Performance and risks of ChatGPT used in drug information: an exploratory real-world analysis	15
Toward a better understanding about real-world evidence	14
Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study	13
Epinephrine use in COVID-19: friend or foe?	12
Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19	12
Investigating the challenges and opportunities for medicines management in an NHS field hospital during the COVID-19 pandemic	12
Analysis of clinical pharmacist interventions in the COVID-19 units of a French university hospital	11
Therapeutic efficacy of tacrolimus in vernal keratoconjunctivitis: a meta-analysis of randomised controlled trials	11
A prospective, observational study to evaluate adverse drug reactions in patients with COVID-19 treated with remdesivir or hydroxychloroquine: a preliminary report	11
Switching of monoclonal antibodies against calcitonin gene-related peptide in chronic migraine in clinical practice: a case series	11
External contamination of antineoplastic drug vials: an occupational risk to consider	9
COVID-19 vaccine triggered autoimmune hepatitis: case report	9
Assessment of the stability of citrate-buffered piperacillin/tazobactam for continuous infusion when stored in two commercially available elastomeric devices for outpatient parenteral antimicrobial ch	9
Petechial skin rash associated with CoronaVac vaccination: first cutaneous side effect report before phase 3 results	9

Impact and acceptance of pharmacist-led interventions during HIV care in a third-level hospital in Spain using the Capacity-Motivation-Opportunity pharmaceutical care model: the IRAFE study	9
Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part B: risk control	9
Impact of CYP2C19 and CYP2C9 gene polymorphisms on sodium valproate plasma concentration in patients with epilepsy	9
The incidence and risk of cutaneous toxicities associated with dabrafenib in melanoma patients: a systematic review and meta-analysis	8
Automated unit dose dispensing systems producing individually packaged and labelled drugs for inpatients: a systematic review	8
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients	8
Predictive performance of reported vancomycin population pharmacokinetic model in patients with different renal function status, especially those with augmented renal clearance	8
Efficacy and safety of PD-1/PD-L1 plus CTLA-4 antibodies ± other therapies in lung cancer: a systematic review and meta-analysis	7
Incidence and associated risk factors of antituberculosis drug-induced hepatotoxicity among hospitalised patients in Wuhan, China	7
Patient prioritisation for hospital pharmacy services: current approaches in the UK	7
Dramatic improvement of bullous pemphigoid with omalizumab in an elderly patient	7
Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part A: risk assessment	7
An update on extravasation: basic knowledge for clinical pharmacists	7
Exploring the adverse effects of chemotherapeutic agents used in the treatment of cervical and ovarian cancer from the patients’ perspective: a content analysis of the online discussion forums	6
Systematic review of the stability of antimicrobial agents in elastomeric devices for outpatient parenteral antimicrobial therapy services based on NHS Yellow Cover Document standards	6
Evaluation of inappropriate antibiotic prescribing and management through pharmacist-led antimicrobial stewardship programmes: a meta-analysis of evidence	6
Therapeutic drug monitoring of amikacin: quantification in plasma by liquid chromatography-tandem mass spectrometry and work experience of clinical pharmacists	6
Impact of pharmacist interventions on drug-related problems in general surgery patients: a randomised controlled trial	6
Consistency of recommendations from clinical practice guidelines for the management of critically ill COVID-19 patients	6
Prescription profile in patients with SARS-CoV-2 infection hospitalised in Aragon, Spain	6
Widening the net: a literature review of antimicrobial agents with potential suitability for outpatient parenteral antimicrobial therapy services—the importance of storage and stability	6
Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series	6
Red for danger in systematic reviews?	5
Outcomes of Clostridioides difficile infection in adult cancer and non-cancer patients hospitalised in a tertiary hospital: a prospective cohort study	5
Effects of antifungal drugs on the plasma concentrations and dosage of tacrolimus in kidney transplant patients	5
Detection of subclinical nephrotoxicity induced by aminoglycosides in critically ill elderly patients using trough levels and urinary neutrophil gelatinase-associated lipocalin	5
Development and validation of a risk prediction model for linezolid-induced thrombocytopenia in elderly patients	5
Assessment of initial vancomycin trough levels and risk factors of vancomycin-induced nephrotoxicity in neonates	5
What influences the implementation and sustainability of antibiotic stewardship programmes in hospitals? A qualitative study of antibiotic pharmacists’ perspectives across South West England	5
Administration of benralizumab in a patient with severe asthma admitted to the intensive care unit with COVID-19 pneumonia: case report	5
Identification and safe storage of look-alike, sound-alike medicines in automated dispensing cabinets	5
The importance of publishing research protocols for pharmacoeconomic studies	5
Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia: a literature review of pharmaceutical and clinical aspects	5
Adverse drug reactions of statin therapy in China from 1989 to 2019: a national database analysis	5
Dabigatran trough concentrations in very elderly patients	5
Omega-3 for the prevention of cardiovascular diseases: meta-analysis and trial-sequential analysis	5
Utility of a trigger tool (TRIGGER-CHRON) to detect adverse events associated with high-alert medications in patients with multimorbidity	5
Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19	5
Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain	5
Physicochemical stability of cefiderocol, a novel siderophore cephalosporin, in syringes at 62.5 mg/mL for continuous administration in intensive care units	4
RETRACTED: Specific features of rational pharmacotherapy in elderly patients	4
Use of simulation for education in hospital pharmaceutical technologies: a systematic review	4
Impact of pharmacist-led interventions in improving adherence to glaucoma medications in the geriatric population	4
Drug-related problems in hospitalised Parkinson’s disease patients in China	4
Managing antibiotic shortages: lessons from EAHP and ECDC surveys	4
Availability of antidotes in Moroccan hospitals: a national survey	4
Developing a telepharmacy programme with home medication dispensing and informed delivery in a tertiary hospital: description of the model and analysis of the results	4
Pharmacy preparations and compounding	4
Do psychotropic drugs used during COVID-19 therapy have an effect on the treatment process?	4
Factors influencing the implementation of clinical pharmacy services on paediatric patient care in hospital settings	4

An unusual case of piperacillin-tazobactam-induced fever, eosinophilia, thrombocytopenia and liver damage	4
Medication persistence on biological therapies prescribed for the treatment of chronic inflammatory arthropathies: a real-world data study	4
Effects of cascade reporting of susceptibility profiles for Enterobacterales on broad-spectrum antibiotics use and resistance	3
Improving the quality of publications in and advancing the paradigms of clinical and social pharmacy practice research: the Granada Statements	3
A patient with ulcerative colitis treated with a combination of vedolizumab and tofacitinib	3
Defining innovativeness of high-technology medical devices in an Italian region	3
Comparison of metaraminol versus no metaraminol on time to resolution of shock in critically ill patients	3
COvid MEdicaTion (COMET) study: protocol for a cohort study	3
Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document	3
Levofloxacin induced bullous fixed drug eruption: a rare case report	3
Cost-saving effect of early less invasive surfactant administration versus continuous positive airway pressure therapy alone for preterm infants with respiratory distress syndrome	3
The European COVID-19 drugs calculation tool: an aid for the estimation of the drugs needed during the SARS-CoV 2 pandemic	3
Surgical pharmacy: the knowledge system of surgical pharmacists	3
5S management improves the service quality in the outpatient-emergency pharmacy: from management process optimisation to staff capacity enhancement	3
Benefit versus toxicity risk of digoxin in patients with COVID-19	3
Prescribing practices of lopinavir/ritonavir, hydroxychloroquine and azithromycin during the COVID-19 epidemic crisis and pharmaceutical interventions in a French teaching hospital	3
Tezacaftor-ivacaftor use in routine care of adults with cystic fibrosis: a medicine use evaluation	3
Tobramycin and vestibulotoxicity: retrospective analysis of four cases	3
Role of the hospital pharmacist in an Italian antimicrobial stewardship programme	3
Effect of a pharmacist-led educational intervention on clinical outcomes: a randomised controlled study in patients with hypertension, type 2 diabetes and hypercholesterolaemia	3
Medication adherence reporting in pivotal clinical trials: overview of oral oncological drugs	3
Criteria for the selection of paediatric patients susceptible to reconciliation error	3
Development of a list with renally relevant drugs as a tool to increase medicines optimisation in patients with chronic kidney disease	3
Lessons learnt from the COVID-19 pandemic: results of EAHP survey on the future crisis preparedness of hospital pharmacies	3
Fighting on two fronts: drug–drug interactions in people living with HIV infected with SARS-CoV-2	3
Improving shared decision-making in pharmacist-led haematology clinics: a ‘Plan Do Study Act’ approach	2
Is it safe to use remdesivir in combination with a combined p-glycoprotein and CYP3A4 inhibitor?	2
Analysis of standard concentrations of continuous infusions in nine Spanish neonatal intensive care units	2
Potential costs and consequences associated with medication error at hospital discharge: an expert judgement study	2
The potential risk factors of nephrotoxicity during vancomycin therapy in Chinese adult patients	2
Stability and compatibility of admixtures containing bupivacaine hydrochloride and ketorolac tromethamine for parenteral use	2
Tocilizumab in COVID-19 management: addressing time of starting treatment	2
Is sitagliptin effective for the treatment of COVID-19?	2
Polymyxin B-related neurotoxicity: a brief case report	2
European health data space proposal launched	2
Analysis of production time and capacity for manual and robotic compounding scenarios for parenteral hazardous drugs	2
Short-term study on in-use stability of opened bevacizumab biosimilar PF-06439535 vials	2
Automatic dispensing cabinets and governance of controlled drugs: an exploratory study in an intensive care unit	2
Antimicrobial resistance: a major priority for global focus	2
Lopinavir/ritonavir, a new galenic oral formulation from commercial solid form, fine-tuned by nuclear magnetic resonance spectroscopy	2
Using risk analysis to anticipate and mitigate failures during a hospital pharmacy relocation	2
Evaluation of the impact of the addition of a heart failure prescribing pharmacist to consultant-led heart failure ward round at a tertiary hospital	2
Observational study of drug-related problems and clinical pharmacists’ interventions in a French paediatric hospital	2
Rosuvastatin-induced rhabdomyolysis: case report and call for proactive multifactorial risk assessment and preventive management of statin therapy in high-risk patients	2
Successful treatment of interstitial pneumonitis with anakinra in a patient with adult-onset Still’s disease	2
Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New Ze	2
Rhabdomyolysis in a male adolescent associated with monotherapy of fluvoxamine	2
Clinical practice and teaching of pharmaceutical care procedures for obstetric diseases	2
Effectiveness of antithrombotic prophylaxis in hospitalised patients with SARS-CoV-2 infection	2
Vancomycin in neonatal sepsis: predictive performance of a Chinese neonatal population pharmacokinetic model and clinical efficacy evaluation	2
Risk of acute kidney injury by initiation of non-steroidal anti-inflammatory drugs in hospitalised patients treated with diuretics and renin–angiotensin–aldosterone system inhibitors	2
Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part C: applying risk assessment and risk control in practice	2
Benefits of using a microencapsulated vitamin D delivery system in women with polycystic ovary syndrome	2
Risperidone is not only a prodrug: psychosis induced by medication switch from risperidone to paliperidone – a case report	2
Drug-related bradycardia precipitating hospital admission in older adults: an ongoing problem	2
Haemolytic anaemia induced by flutamide: a case report	2
Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors	2
Use of chronic medications and risk of death due to COVID-19 in hospitalised patients	2
Effects of angiotensin II receptor blockers on serum potassium level and hyperkalemia risk: retrospective single-centre analysis	2
Is it safe to use visible blue light-emitting diode phototherapy for neonatal jaundice in infants who are also treated with amiodarone?	2
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in a paediatric patient taking zonisamide	2
Rational selection of inhalation devices in the treatment of chronic obstructive pulmonary disease by means of the System of Objectified Judgement Analysis (SOJA)	2
Therapeutic drug monitoring of linezolid: HPLC-based assays for routine quantification of linezolid in human serum and cerebrospinal fluid	2
Off-label use of inhaled bronchodilators in hospitalised patients in Spain: a multicentre observational study	2
How can we optimise the pharmaceutical analysis of radiopharmaceutical pediatric prescriptions?	2
EMA/HMA joint statement on the scientific rationale supporting interchangeability of biosimilar medicines in the EU	2
Economic evaluation of subcutaneous versus intravenous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy: a real-life study	2
Hospital pharmacy response to COVID-19 at two UK teaching hospitals: a departmental review of actions implemented to inform future strategy	2
Impact of automated dispensing cabinets on dispensing errors, interruptions and pillbox preparation time	2
Unexpected overdose of oral cyclosporine in a kidney transplant patient: a case report	2
Successful treatment of Verona integron-encoded metallo-β-lactamase-producingKlebsiella pneumoniaeinfection using the combination of ceftazidime/avibactam and aztreonam	2
Pharmacokinetic/pharmacodynamic analysis of vancomycin in patients withEnterococcus faeciumbacteraemia: a retrospective cohort study	2
Antimicrobial resistance in Nigeria: challenges and charting the way forward	2
Evaluation of amikacin dosing schedule in critically ill elderly patients with different stages of renal dysfunction	2
Comparison of area under the curve for vancomycin from one- and two-compartment models using sparse data	2
Comparison of three automated compounding devices for parenteral nutrition according to four key technical tests	2
Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients	2
Use of dornase alfa in the paediatric intensive care unit: current literature and a national cross-sectional survey	2
A qualitative evaluation of weekly reflective practice sessions for the intensive care unit pharmacy team during the COVID-19 pandemic	2
Patient perspectives of successful adalimumab biosimilar transitioning in Crohn’s disease: an interview study	2

In-use stability of diluted thiamazole (methimazole) infusion solutions in prefilled 0.9% sodium chloride infusion bags for continuous infusion	2
Design and validation of a predictive equation to estimate unbound valproic acid concentration	2
Formulation and stability of an extemporaneously compounded propafenone hydrochloride oral suspension for children with arrhythmia	2
Development and validation of a ready-to-use score to prioritise medication reconciliation at patient admission in an orthopaedic and trauma department	2
Clinical frailty and polypharmacy in older emergency critical care patients: a single-centre retrospective case series	2
Haemorrhagic complications in patients with renal insufficiency during treatment or prophylaxis with dalteparin	2
Pharmacotherapeutic management of Parkinson’s disease inpatients: how about asking hospital pharmacists?	2
Monoclonal antibodies for the early treatment of paediatric COVID-19 patients: a tangible contribution from hospital pharmacists in the lack of evidence	2
Web searches for anxiolytic drugs during the COVID-19 outbreak in the USA	2
Analysis of the third WHO Global Safety Challenge ‘Medication Without Harm’ patient-facing materials: exploratory descriptive study	2
Medication-related problems in critical care survivors: a systematic review	2
Haematology patients infected with SARS-CoV-2, pretreated with eculizumab or siltuximab, develop oligosymptomatic disease	1
Public consultation for European health data space is open	1
Evaluating the effectiveness of digital communication within the National Medication Safety Network for England	1
Hydrocortisone-induced blood pressure reduction in a patient with anterior pituitary hypofunction: a case report	1
Compliance with status epilepticus management protocol and effect on clinical outcomes in children with status epilepticus	1
Hospital pharmacy specialisation	1
Renal profile of patients treated with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort	1
Global research trends and hotspots in pharmaceutical care: a bibliometric analysis and visualisation using CiteSpace and VOSviewer	1
Prospective observational study of medication reviews in internal medicine wards: evaluation of drug-related problems	1
Evaluation of drug interaction between cyclosporine and lercanidipine: a descriptive study	1
Analysis of the clinical characteristics of dabigatran-induced oesophagitis	1
Impact of non-formulary drugs on pharmacological prescription in hospitalised patients	1
Public information on shortages in the EU/EEA: improvements made between 2018 and 2020	1
Long-term effectiveness and pharmacokinetics of the infliximab biosimilar CT-P13 after switching from the originator during the treatment of inflammatory bowel disease	1
Extemporaneous preparation of rifampicin granules from capsules to improve usability	1
Factors affecting voriconazole concentration to dose ratio changes according to route of administration	1
Impact of a pharmaceutical intervention on influenza vaccination in patients receiving treatment with biological medicines	1
Recent initiatives to enhance the safety of intravenous medications in Chinese hospitals	1
Transition to adult services: the current and potential role of the UK hospital pharmacist	1
Piperacillin/tazobactam-induced coagulopathy in a patient through a vitamin K-dependent mechanism	1
Analytical and clinical validation of an LC-MS/MS method for carbamazepine, lamotrigine and levetiracetam in dried blood spots	1
Digitalisation of the drug prescribing process in Swiss hospitals – results of a survey	1
Physicochemical stability of carmustine-containing medicinal products after reconstitution and after dilution to ready-to-administer infusion solutions stored refrigerated or at room temperature	1
Some reflections on the current COVID-19 pandemic	1
Potential therapeutic effects of different mouthwashes for alleviation and treatment of oral complications of 5-fluorouracil-based chemotherapy in patients with colon cancer	1
Infliximab: a single-centre, prospective, observational evaluation of TDM data in patients with IBD	1
Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendations	1
Using Healthcare Failure Mode and Effect Analysis in prospective medication safety risk management in secondary care inpatient wards	1
COVID-19 vaccine triggered autoimmune hepatitis: case report	1
A pharmacist-led intervention to improve kidney transplant recipient outcomes and identify patients at risk of highly variable trough tacrolimus levels: a cohort study	1
Fatal hepatotoxicity due to sevoflurane use in a paediatric patient after aortic repair: reality or fiction? A case of pharmacovigilance	1
Physicochemical stability of ready-to-administer mitomycin C solutions for intravesical instillation	1
Hand hygiene for healthcare workers: did we need COVID-19 to raise awareness of proper disinfection practice?	1
SARS-COV-2 pandemic: establishing three risk levels for 19 Italian regions and two autonomous provinces	1
The Granada Statements: an impact boost to clinical and social pharmacy publications, part 1	1
Effects of pretreatment with terazosin and valsartan on intraoperative haemodynamics in patients with phaeochromocytoma	1
Self-administration of medications in inpatient postnatal women: an opportunity to empower self-care, improved medicines knowledge and adherence utilising clinical pharmacists and midwifery workforce	1
Failure mode and effect analysis applied to improve the medication management process in a pharmacy of a teaching hospital and a proposal for a simplified rating system	1
Analysis of medication-related triggers to determine adverse drug events	1
Risk factors for early onset acute kidney injury after allogeneic haematopoietic stem cell transplantation and the role of drug–drug interactions	1
Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients	1
Implementation of pharmacists’ monitoring for intravenous drug compatibility	1
Beta-lactam allergy in patients: an antibiotic stewardship challenge	1
The novice researcher	1
Information on COVID-19 vaccines and vaccinations	1
Putting the patient at the centre – Pharmaceutical Strategy for Europe welcomed by hospital pharmacists	1
Rare complication of doxorubicin-induced complete heart block in a patient with Hodgkin’s lymphoma: a case report	1
Off-label use in adult palliative care – more common than expected. A retrospective chart review	1
A retrospective hospital benefit and cost analysis of the management of human tissues for orthopaedic allografts	1
Potential impact of national recommendations to use short course antibiotic therapy on antibiotic use in the emergency department of a UK hospital: retrospective observational study	1
Successful desensitisation to paclitaxel with omalizumab	1
Antimicrobial resistance—a global challenge that deserves more attention!	1
Assessment of the effectiveness of tocilizumab on mortality and progression to mechanical ventilation or intensive care in patients with COVID-19 admitted to a tertiary hospital	1
Pharmacists’ considerations on non-medical switching at the hospital: a systematic review of the economic outcomes of cost-saving therapeutic drug classes	1
Automated preparation of cytotoxic drugs: the evidence for an interface between the robot and computerized provider order entry?	1
Rare case report of moxifloxacin-induced persistent hiccups	1
Financial impact of the hospital pharmacy’s participation in clinical trials	1
Visual compatibility and particle counter evaluations of syringes of intramuscular psychotropic coadministered solutions	1
Acute onset psychosis with complex neurobehavioural symptomatology following the intramuscular injection of hyoscine butylbromide: a case report with an overview of the literature	1
Should vericiguat be initiated in geriatric inpatients with heart failure with reduced ejection fraction and a worsening heart failure event prior to discharge?	1
Importance of medication reconciliation, even in the absence of positive data	1
Stability of pemetrexed diarginine concentrates for solution in vials and diluted in 0.9% sodium chloride and dextrose 5% polyolefin infusion bags	1
Process performance of a new liquid medication dispensing robot	1
Combination of ceftaroline and daptomycin as treatment for complicated osteomyelitis	1
Sulperazon-induced acute reactive thrombocytopenia during treatment of systemic lupus erythematosus: a case report	1
Clinical pharmacists’ services, role and acceptance: a national Swedish survey	1
Position paper on pharmacy preparations and compounding	1
Crushing lopinavir/ritonavir tablets does not result in lower exposure to lopinavir/ritonavir in adult patients with COVID-19	1
Comparison of outcomes for fixed and weight-based four-factor prothrombin complex concentrate dosing regimens	1
Multiprofessional intervention to improve adherence to medication in stroke patients: a study protocol for a randomised controlled trial (ADMED AVC study)	1
Development and Delphi validation of a Best Possible Medication History form	1
Treatment of high-risk bleeding with susoctocog alfa in a patient with acquired haemophilia A and a nosocomial severe acute respiratory syndrome coronavirus 2 infection	1
The geriatric clinical pharmacist at the emergency department: a novel front-door transdisciplinary care model	1
Safety and effectiveness of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal following a fixed-dose strategy	1
In-hospital expenditure for medical devices in relation to funds from diagnosis-related groups and ambulatory activity: temporal trend from 2019 to 2022	1
Informing critical care drug requirements in response to the COVID-19 pandemic	1
The PEPSIN project: design and validation of a self-administered questionnaire for the assessment of equivalence between pens and prefilled syringes in patients on subcutaneous biological drugs	1
Experience in managing independent clinical research, the best training strategy for future clinical pharmacists: the QOSMOS project	1
Game-based training to promote handwashing, handrub and gloving for hospital pharmacy operators	1
Show how you keep antibiotics working during this year’s EAAD	1
Real-world effectiveness and factors associated with increased mortality in non-critically ill patients with COVID-19 pneumonia receiving remdesivir	1
Epileptic convulsions probably induced by desloratadine: a case report	1
Assessment of the effectiveness of a pharmacist approach for improving disease-specific knowledge and treatment in patients with chronic obstructive pulmonary disease	1
What about cardiovascular toxicities of immune checkpoint inhibitors?	1